the year ended December 31, 2018 The Company reported net loss for the year 2018 of Baht 195.83 million, comparing with the same period last year which had net profit of Baht 9.87 million, decreasing by

result. Dear sir, We, Unimit Engineering Public Company Limited (UEC), would like to clarify the change in the operating results for Q3/2019 which has had a change of over 20% from the same period last

Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2019 as follows. Summary The Company

19% 1,209 10% -16% EBITDA 660 18% 1,156 34% 75% 2,487 33% 3,295 27% 32% Normalized EBITDA 1 803 22% 624 18% -22% 1,622 22% 2,484 20% 53% Normalized Profit for the period after NCI 1 448 12% -34 -1

income tax expense 235.13 122.44 -47.93% Income tax expense (13.23) (0.45) -96.60% Profit for the period 221.90 121.99 -45.02% 2018 2019 %YoYIncome Statement (in million Baht) -2- Cost of Sales Cost of

over 20% from the same period last year. Unimit and its subsidiaries have contract revenues that amount to Baht 888 million in 2019, which is an increase of around Baht 43 million (5%) with a net loss of

same period of last year. The increased net profit for year 2019 was mainly in respond to the product mix during the year and that the impacts derived from the currencies appreciation is at lesser level

Company and its subsidiaries recorded the total revenues of 4,581 MTHB of which 4,557 MTHB earned from sales revenues. Sales revenues increased by 621 MTHB or 15.8% comparing to the same period of the year

(there has been no connected transaction occurred during the last six-month period). Therefore this transaction is not required (i) the Board of Directors approval; (ii) shareholders approval; and (iii

financial statement ended June 30,2017) Nevertheless, calculation including other transaction occurring during a period of six months still less than15%. Moreover, the counterparty of the transaction was